Combining of chemotherapy with targeted therapy for advanced biliary tract cancer: A systematic review and meta-analysis

doi:10.4251/wjgo.v14.i10.2061

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3639)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

137

WORD

HTML

1642

Figures (1-6)

200

Tables (1-2)

207

Sum=2237

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

352

Download

1050

Sum=1402

Oct 15, 2022 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastrointest Oncol. Oct 15, 2022; 14(10): 2061-2076
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.2061

Full Size Figure Download Figure

Figure 2 Forest plots on the assessment of objective response rate in biliary tract cancer patients treated with chemotherapy + targeted therapy or chemotherapy alone. A: Overall population; B: Subgroup analysis according to agent targets; C: Subgroup analysis according to chemotherapy regimens. CT: Chemotherapy; TT: Targeted therapy; EGFR: Epidermal growth factor receptor; VEGFR: Vascular endothelial growth factor receptor; MET: Mesenchymal-epithelial transition factor.

Citation: Bai XS, Zhou SN, Jin YQ, He XD. Combining of chemotherapy with targeted therapy for advanced biliary tract cancer: A systematic review and meta-analysis. World J Gastrointest Oncol 2022; 14(10): 2061-2076
URL: https://www.wjgnet.com/1948-5204/full/v14/i10/2061.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i10.2061